Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

21-Jan-21 - 21-Apr-21
Buy Ratio:25%

Down

# Net Buyers:47
# Net Sellers:144

Previous 13 Weeks

22-Oct-20 - 20-Jan-21
Buy Ratio:27%
# Net Buyers:51
# Net Sellers:140
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Catalent, Inc.($27.48M)$509.86M  
Eli Lilly & Co$11.56M$130.33M  
Five Prime Therapeutics, Inc.($22.05M)$128.07M  
Mirati Therapeutics, Inc.($81.52M)$100.00M  
Ptc Therapeutics, Inc.($799.32K)$59.79M  
New Net Buyers
CompanyNet Buy AmountChange
Eli Lilly & Co$11.56M$130.33M  
Merck & Co., Inc.$26.10M$48.54M  
Cti Biopharma Corp$5.00M$12.00M  
Precigen, Inc.$576.48K$3.67M  
Cardiff Oncology, Inc.$298.48K$955.50K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Usana Health Sciences Inc($54.52M)($53.52M)  
Abbott Laboratories($61.56M)($51.98M)  
Amyris, Inc.($70.00M)($47.22M)  
Ligand Pharmaceuticals Inc($38.66M)($38.40M)  
Infinity Pharmaceuticals, Inc.($36.34M)($36.34M)  
New Net Sellers
CompanyNet Buy AmountChange
Lexicon Pharmaceuticals, Inc.($1.20M)($36.20M)  
Rocket Pharmaceuticals, Inc.($8.98M)($21.91M)  
Eyegate Pharmaceuticals Inc($58.55K)($8.05M)  
Meridian Bioscience Inc($5.97M)($5.98M)  
Kalvista Pharmaceuticals, Inc.($3.15M)($4.77M)